|
GB201713553D0
|
|
Drug intermediates diphenyl acetone synthesis method
|
|
GB201713401D0
|
|
Drug intermediates 3-ene hexenoic acid synthesis method
|
|
GB201713405D0
|
|
Organic synthesis intermediates 4-iodobenzaldehyde synthesis method
|
|
CN106008226A
|
|
Synthesis method of diflunisal drug intermediate 2,4-difluoroaniline
|
|
CN105859518A
|
|
Synthetic method for flunarizine drug intermediate bis 4-fluorophenyl methyl alcohol
|
|
CN105859605A
|
|
Synthetic method of awakening drug intermediate 1,3,3-trimethyl-5-hydroxy indole hydrochloride
|
|
CN105777559A
|
|
Synthesis method of nifekalant hydrochloride medical intermediate 2-[3-(4-nitrophenyl) propyl amino] ethyl alcohol
|
|
CN105439944A
|
|
Synthesis method of disopyramide drug intermediate 2-bromopyridine
|
|
CN105503651A
|
|
Synthetic method for methanesulfonic phentolamine drug intermediate chloroacetonitrile
|
|
CN105669636A
|
|
Synthetic method for bifendate medicine intermediate 3-methoxy-4,5-methylenedioxymethyl benzoate
|
|
CN105566109A
|
|
Method for synthesizing carbenicillin sodium pharmaceutical intermediate diethyl(phenylmethylene)malonate
|
|
CN105503506A
|
|
Method for synthesis of non-steroidal anti-inflammatory drug diclofenac drug intermediate cyclohexene
|
|
CN105503697A
|
|
Synthesis method for doxepin drug intermediate phthalic diamide
|
|
CN105622373A
|
|
Synthetic method for 4-hexyl-1,3-benzenediol drug intermediate 2-heptanone
|
|
CN105503494A
|
|
Synthetic method for medical intermediate cyclopentene of ketamine
|
|
CN105503493A
|
|
Synthesis method for flavonoid compound drug intermediate 1,1-diphenyl-1-propylene
|
|
CN105503564A
|
|
Method for synthesizing clofibrate drug intermediate 2-(4-Chlorophenoxy)-2-methylpropionic acid
|
|
CN105503491A
|
|
Synthesis method of terbinafine medical intermediate tert-butyl acetylene
|
|
CN105541658A
|
|
Synthetic method of drug intermediate azidobenzene of aza-purine
|
|
CN105481669A
|
|
Synthesis method of nafcillin sodium drug intermediate 2-ethoxy-1-naphthaldehyde
|
